Research ArticleHeart Failure

Central-acting therapeutics alleviate respiratory weakness caused by heart failure–induced ventilatory overdrive

See allHide authors and affiliations

Science Translational Medicine  17 May 2017:
Vol. 9, Issue 390, eaag1303
DOI: 10.1126/scitranslmed.aag1303

Article Information

vol. 9 no. 390

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication May 12, 2016
  • Accepted for publication March 13, 2017

Author Information

  1. Andrew J. Foster1,*,
  2. Mathew J. Platt1,*,
  3. Jason S. Huber1,
  4. Ashley L. Eadie2,
  5. Alicia M. Arkell1,
  6. Nadya Romanova1,
  7. David C. Wright1,
  8. Todd E. Gillis3,
  9. Coral L. Murrant1,
  10. Keith R. Brunt2, and
  11. Jeremy A. Simpson1,
  1. 1Department of Human Health and Nutritional Science, University of Guelph, Guelph, Ontario N1G 2W1, Canada.
  2. 2Department of Pharmacology, Dalhousie Medicine, Saint John, New Brunswick E2L 4L5, Canada.
  3. 3Department of Integrative Biology, University of Guelph, Guelph, Ontario N1G 2W1, Canada.
  1. Corresponding author. Email: jeremys{at}uoguelph.ca (J.A.S.); keith.brunt{at}dal.ca (K.R.B.)
    • * These authors contributed equally to this work.

    Altmetric

    Article usage

    Article usage: May 2017 to October 2018

    AbstractFullPdf
    May 201775251066971
    Jun 20174343254
    Jul 20172651726
    Aug 20171812220
    Sep 20171951722
    Oct 20171902222
    Nov 20171712018
    Dec 20171091710
    Jan 20181031216
    Feb 2018107197
    Mar 2018127166
    Apr 2018111116
    May 20181081110
    Jun 2018118139
    Jul 201888811
    Aug 2018631212
    Sep 2018591610
    Oct 2018361211